IN-VITRO COMPARISON OF DU-6859A, A NOVEL FLUOROQUINOLONE, WITH OTHER QUINOLONES AND OPAL CEPHALOSPORINS TESTED AGAINST 5086 RECENT CLINICAL ISOLATES

被引:10
作者
MARSHALL, SA
JONES, RN
MURRAY, PR
WASHINGTON, JA
ALLEN, SD
GERLACH, EH
ERWIN, ME
机构
[1] UNIV IOWA,COLL MED,IOWA CITY,IA 52242
[2] WASHINGTON UNIV,MED CTR,ST LOUIS,MO 63110
[3] CLEVELAND CLIN FDN,CLEVELAND,OH 44195
[4] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46223
[5] ST FRANCIS REG MED CTR,WICHITA,KS 67214
关键词
D O I
10.1093/jac/32.6.877
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:877 / 884
页数:8
相关论文
共 11 条
  • [1] RESISTANCE TO CIPROFLOXACIN APPEARING DURING THERAPY
    CHIN, NX
    CLYNES, N
    NEU, HC
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 87 (5A) : S28 - S31
  • [2] HOSHINO K, 1991, 31 INT C ANT AG CHEM, P350
  • [3] Jones R. N., 1988, Antimicrobic Newsletter, V5, P1, DOI 10.1016/0738-1751(88)90015-9
  • [5] OFLOXACIN, A NEW BROAD-SPECTRUM FLUOROQUINOLONE - RESULTS FROM A MULTICENTER, NATIONAL COMPARATIVE ACTIVITY SURVEILLANCE STUDY
    JONES, RN
    RELLER, LB
    ROSATI, LA
    ERWIN, ME
    SANCHEZ, ML
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (05) : 425 - 434
  • [6] JONES RN, 1992, ANTIBIOTIC NEWSLETTE, V15, P177
  • [7] OKAZAKI O, 1991, 31ST INT C ANT AG CH, P350
  • [8] ANTIMICROBIAL ACTIVITY OF DU-6859, A NEW POTENT FLUOROQUINOLONE, AGAINST CLINICAL ISOLATES
    SATO, K
    HOSHINO, K
    TANAKA, M
    HAYAKAWA, I
    OSADA, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) : 1491 - 1498
  • [9] SHIMADA H, 1991, 31ST INT C ANT AG CH, P350
  • [10] WOLFSON J S, 1992, Clinical Microbiology Newsletter, V14, P1, DOI 10.1016/0196-4399(92)90091-M